Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 27011-27020 Newer>

The Motley Fool October 31, 2007 Morgan Housel	Winning Isn't Everything It's a hard thing to do, but at the end of the day, don't focus on how much money you made. How you go about investing is more important than how you perform.
The Motley Fool October 31, 2007 Brian Lawler	The Next Hepatitis C Blockbuster? Never before have there been so many new drugs in development to treat Hepatitis C. Which companies have the compounds most likely to win this race? Investors, take note.
The Motley Fool October 31, 2007 Rich Smith	Foolish Forecast: Mobile Mini Fails to Thrill In advance of earnings, analysts expect portable storage specialist Mobile Mini to show growth in sales, while profits are expected to be flat.
The Motley Fool October 31, 2007 Matt Koppenheffer	Goldman: Superhero or Ticking Time Bomb? Goldman Sachs is 50% above its August lows and hitting new 52-week highs; will it be able to completely sidestep the problems that are clobbering its competitors?
The Motley Fool October 31, 2007 Dave Mock	InterDigital Doesn't Disappoint The wireless technology developer treats investors to solid quarterly earnings and continued optimism for the full year.
The Motley Fool October 31, 2007 Tom Taulli	Is Tech Ready to Go Deal-Crazy? Over the past couple of months, tech companies such as SAP, McAfee, Microsoft, and Oracle have made some interesting M&A deals. Is this the start of a major trend?
The Motley Fool October 31, 2007 Alyce Lomax	Is Chipotle Overstuffed With Optimism? Chipotle's success is evident in the stock's meteoric rise; it's up 137% in the past 12 months. Latest quarterly results were strong, but how much growth is left in the Mexican restaurant chain?
The Motley Fool October 31, 2007 Rich Smith	Foolish Forecast: Will Morningstar Miss? In advance of earnings reports, analysts expect mutual fund rater Morningstar to turn in sales and earnings increases.
The Motley Fool October 31, 2007 Brian Lawler	Depomed Plays Hot Potato Following disappointing sales numbers, King Pharmaceuticals and Depomed terminate their marketing collaboration deal.
The Motley Fool October 31, 2007 Toby Shute	Hercules' Unheroic Outing The shallow-water driller faces tough market conditions, and turns in a disappointing, but not surprising, quarter.
<Older 27011-27020 Newer> Return to current articles.